Recombinant DNA Infectious organisms and viruses (like parasites, bacteria, fungi, prions, and viroids) Biologically active agents (like toxins, allergens, and venoms) Human blood and blood products ...

With the prospect of HIV, first recognized in 1984, infecting 1% of the world's population by the year 2000, the need for the development of a vaccine for AIDS is urgent 1. Challenges for an effective ...

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.

You have full access to this article via your institution. To demonstrate the power of PCR–mediated recombination and provide an example of the general utility of the method, we constructed chimeric ...

According to MarketsandMarketstm, the Elemental Analysis Market is projected to grow from about USD 4.54 billion in 2025 to USD 6.49 billion by 2030, at a CAGR of 7.4%. Browse 350 market data tables ...

Investigators in the Nancy Guthrie case have turned to genetic genealogy as they try to make the most of potential DNA ...

Most people alive today carry fragments of Neanderthal DNA in their genome. Now scientists are gaining a more intimate ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses. Many existing options rely on molecules ...

Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health ...

For the first time, researchers have succeeded in developing an artificial DNA base pair that is based on a different chemical force than natural genetic material. While the common natural DNA ...

When ancient humans mated, dad was a Neanderthal, mom was Homo sapiens.